Predicted protein targets (top 2)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR119 | Q8TDV5 | 20/20 | 0.62 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2406808 | 0.99 | GPR119 (0.62) | GPR119CYP2C9 | |
| SCHEMBL6364037 | 0.97 | GPR119 (0.63) | GPR119CYP2C9 | |
| SCHEMBL388811 | 0.92 | GPR119 (0.63) | GPR119CYP2C9 | |
| SCHEMBL390422 | 0.91 | GPR119 (0.64) | GPR119CYP2C9 | |
| SCHEMBL387984 | 0.90 | GPR119 (0.65) | GPR119CYP2C9 | |
| SCHEMBL389153 | 0.88 | GPR119 (0.66) | GPR119CYP2C9 | |
| SCHEMBL386007 | 0.88 | GPR119 (0.63) | GPR119CYP2C9 | |
| SCHEMBL2405093 | 0.88 | GPR119 (0.65) | GPR119CYP2C9 | |
| SCHEMBL390765 | 0.87 | GPR119 (0.67) | GPR119CYP2C9 | |
| SCHEMBL2404810 | 0.87 | GPR119 (0.66) | GPR119CYP2C9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2005007647-A9 | TRISUBSTITUTED ARYL AND HETEROARYL DERIVATIVES AS MODULATORS OF METABOLISM AND THE PROPHYLAXIS AND TREATMENT OF DISORDERS RELATED THERETO | ARENA PHARM INC (US) | 2005-04-07 | — | — | WO | claimed |
| EP-2004157-A2 | USE OF GPR119 RECEPTOR AGONISTS FOR INCREASING BONE MASS AND FOR TREATING OSTEOPOROSIS, AS WELL AS COMBINATION THERAPY RELATING THERETO | Arena Pharmaceuticals, Inc. (US) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007120702-A2 | USE OF GPR119 RECEPTOR AGONISTS FOR INCREASING BONE MASS AND FOR TREATING OSTEOPOROSIS, AND COMBINATION THERAPY RELATING THERETO | ARENA PHARMACEUTICALS, INC. (US) | 2007-10-25 | — | — | WO | disclosed |